Literature DB >> 27063524

Prevalence and severity of dry eye in candidates for laser in situ keratomileusis for myopia in Russia.

Dmitry Yurevich Maychuk1.   

Abstract

PURPOSE: To assess the prevalence and severity of dry-eye disease in patients with myopia being evaluated for laser in situ keratomileusis.
SETTING: Nine ophthalmology centers in Russia.
DESIGN: Prospective noninterventional cross-sectional study.
METHODS: The assessments included the Schirmer I test, tear breakup time (TBUT), lissamine green and fluorescein staining (Oxford grading scheme), Ocular Surface Disease Index (OSDI) questionnaire, and Dry Eye Workshop (DEWS) dry-eye severity grading.
RESULTS: The study comprised 400 patients with myopia (mean age 29.7 years); 145 (36.2%) wore contact lenses, and 81 (20.2%) used topical dry-eye medication. The mean Schirmer test score was 15.2 mm; 36.5% of patients had evidence of tear-volume deficiency (Schirmer score ≤10 mm). The mean TBUT was 11.7 seconds; 10.1% of patients had tear-film instability (TBUT <5 seconds). Conjunctival (lissamine green) staining intensity was categorized as minimal or greater (grade ≥1) in 62.3% of patients and mild or greater (grade ≥2) in 22.8% of patients. The mean OSDI score was 20.4, indicating mild ocular disability. Dry-eye severity (DEWS grading) was mild/episodic in 66.2%, moderate in 29.5%, and severe in 4.3% of patients. No clear correlation was evident between the Schirmer/TBUT scores and the lissamine green/OSDI scores.
CONCLUSIONS: The prevalence of dry eye in this population was estimated at approximately 10% to 40% (based on clinical signs) and 40% to 55% (based on symptoms); dry-eye severity was predominantly mild/episodic. The proportion of patients requiring dry-eye therapy (based on OSDI and DEWS severity findings) was almost 2 times higher than the proportion receiving treatment.
Copyright © 2016 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27063524     DOI: 10.1016/j.jcrs.2015.11.038

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  4 in total

1.  Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study.

Authors:  Marguerite B McDonald; Hosam Sheha; Sean Tighe; Susan B Janik; Frank W Bowden; Amit R Chokshi; Michael A Singer; Seema Nanda; Mujtaba A Qazi; Damon Dierker; Adam T Shupe; Brittany J McMurren
Journal:  Clin Ophthalmol       Date:  2018-04-09

2.  Meibomian Gland Morphology Among Patients Presenting for Refractive Surgery Evaluation.

Authors:  Cassandra C Brooks; Preeya K Gupta
Journal:  Clin Ophthalmol       Date:  2021-01-27

Review 3.  Call to action: treating dry eye disease and setting the foundation for successful surgery.

Authors:  Kendall Donaldson; Gregory Parkhurst; Bobby Saenz; Walter Whitley; Blake Williamson; John Hovanesian
Journal:  J Cataract Refract Surg       Date:  2021-10-19       Impact factor: 3.528

4.  Corneal Nerve Regeneration after Self-Retained Cryopreserved Amniotic Membrane in Dry Eye Disease.

Authors:  Thomas John; Sean Tighe; Hosam Sheha; Pedram Hamrah; Zeina M Salem; Anny M S Cheng; Ming X Wang; Nathan D Rock
Journal:  J Ophthalmol       Date:  2017-08-15       Impact factor: 1.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.